Product Code: GVR-4-68040-638-6
Market Size & Trends:
The U.S. 3D medical imaging devices market size was valued at USD 3.69 billion in 2024 and is projected to grow at a CAGR of 8.0% from 2025 to 2030. The rising prevalence of chronic disorders, an increasing preference for minimally invasive procedures, technological advancements, and the growing aging population are the major factors contributing to the growth of the U.S. 3D medical imaging devices industry. The growing prevalence of chronic disorders, such as Cardiovascular Disorders (CVDs), cancer, and neurological conditions, further contributes to market growth. According to data on cancer published by the U.S. Centers for Disease Control and Prevention (CDC), 1,777,566 new invasive cancer cases were reported in 2021, with an age-adjusted rate of 445.8 per 100,000 people. These conditions often require precise and detailed imaging for early detection, diagnosis, and treatment planning. Medical 3D imaging technologies, such as MRI and CT scans, offer healthcare professionals three-dimensional views of anatomical structures and abnormalities, supporting better decision-making and enhancing patient care.
The evolution of 3D medical imaging has improved its efficiency, providing healthcare professionals with better tools for accurate diagnosis and treatment planning. These technologies allow for detailed visualization of anatomical structures, aiding in detecting and managing complex conditions. Furthermore, continuous advancements, such as improved imaging quality, integration of AI, and enhanced device capabilities, further support market growth.
The growing preference for minimally invasive procedures further drives the adoption of 3D imaging technologies in surgical and interventional settings. These advanced imaging devices provide detailed and accurate visualization of complex anatomical structures, enabling surgeons and interventional radiologists to plan procedures more effectively. 3D images enable them to navigate challenging areas more precisely, ensuring that treatment is accurately targeted while minimizing damage to surrounding tissues. This approach helps enhance the safety and efficacy of procedures, enables quicker recovery, reduces risks of complications, and improves overall patient outcomes.
U.S. 3D Medical Imaging Devices Market Report Segmentation
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. 3D medical imaging devices market report based on device type, hardware, application, and end use.
- Device Type Outlook (Revenue, USD Billion, 2018 - 2030)
- Hardware
- Software
- Hardware Outlook (Revenue, USD Billion, 2018 - 2030)
- X-ray Devices
- CT Devices
- Ultrasound Systems
- MRI Equipment
- Application Outlook (Revenue, USD Billion, 2018 - 2030)
- Oncology
- Cardiology
- Orthopedic
- Gynaecology
- Others
- End Use Outlook (Revenue, USD Billion, 2018 - 2030)
- Hospitals
- Diagnostic Imaging Centers
- Others
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Device Type
- 1.2.2. Hardware
- 1.2.3. Application
- 1.2.4. End Use
- 1.2.5. Estimates and Forecasts Timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR's Internal Database
- 1.4.3. Secondary Sources
- 1.4.4. Primary Research
- 1.4.5. Details of Primary Research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market formulation & Validation
- 1.7. Model Details
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Device Type Outlook
- 2.2.2. Hardware Outlook
- 2.2.3. Application Outlook
- 2.2.4. End Use Outlook
- 2.3. Competitive Insights
Chapter 3. U.S. 3D Medical Imaging Devices Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. U.S. 3D Medical Imaging Devices Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier Power
- 3.3.1.2. Buyer Power
- 3.3.1.3. Substitution Threat
- 3.3.1.4. Threat of New Entrants
- 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political Landscape
- 3.3.2.2. Technological Landscape
- 3.3.2.3. Economic Landscape
- 3.4. U.S. 3D Medical Imaging Devices Market: Pipeline Analysis
Chapter 4. U.S. 3D Medical Imaging Devices Market: Device Type Estimates & Trend Analysis
- 4.1. Device Type Segment Dashboard
- 4.2. U.S. 3D Medical Imaging Devices Market: Device Type Movement Analysis
- 4.3. U.S. 3D Medical Imaging Devices Market Size & Trend Analysis, by Device Type, 2018 to 2030 (USD Billion)
- 4.4. Hardware
- 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
- 4.5. Software
- 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
Chapter 5. U.S. 3D Medical Imaging Devices Market: Hardware Estimates & Trend Analysis
- 5.1. Hardware Segment Dashboard
- 5.2. U.S. 3D Medical Imaging Devices Market: Hardware Movement Analysis
- 5.3. U.S. 3D Medical Imaging Devices Market Size & Trend Analysis, by Hardware, 2018 to 2030 (USD Billion)
- 5.4. X-ray Devices
- 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
- 5.5. CT Devices
- 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
- 5.6. Ultrasound Systems
- 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
- 5.7. MRI Equipment
- 5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
Chapter 6. U.S. 3D Medical Imaging Devices Market: Application Estimates & Trend Analysis
- 6.1. Application Segment Dashboard
- 6.2. U.S. 3D Medical Imaging Devices Market: Application Movement Analysis
- 6.3. U.S. 3D Medical Imaging Devices Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Billion)
- 6.4. Oncology
- 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
- 6.5. Cardiology
- 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
- 6.6. Orthopedic
- 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
- 6.7. Gynecology
- 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
- 6.8. Others
- 6.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
Chapter 7. U.S. 3D Medical Imaging Devices Market: End Use Estimates & Trend Analysis
- 7.1. Hospitals
- 7.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
- 7.2. Diagnostic Imaging Centers
- 7.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
- 7.3. Others
- 7.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.3. Vendor Landscape
- 8.3.1. Key Company Heat Map Analysis, 2024
- 8.4. Company Profiles
- 8.4.1. Siemens Healthineers AG
- 8.4.1.1. Company Overview
- 8.4.1.2. Financial Performance
- 8.4.1.3. Device Benchmarking
- 8.4.1.4. Strategic Initiatives
- 8.4.2. Esaote SPA
- 8.4.2.1. Company Overview
- 8.4.2.2. Financial Performance
- 8.4.2.3. Device Benchmarking
- 8.4.2.4. Strategic Initiatives
- 8.4.3. Koninklijke Philips N.V.
- 8.4.3.1. Company Overview
- 8.4.3.2. Financial Performance
- 8.4.3.3. Device Benchmarking
- 8.4.3.4. Strategic Initiatives
- 8.4.4. GE Healthcare
- 8.4.4.1. Company Overview
- 8.4.4.2. Financial Performance
- 8.4.4.3. Device Benchmarking
- 8.4.4.4. Strategic Initiatives
- 8.4.5. CANON MEDICAL SYSTEMS CORPORATION
- 8.4.5.1. Company Overview
- 8.4.5.2. Financial Performance
- 8.4.5.3. Device Benchmarking
- 8.4.5.4. Strategic Initiatives
- 8.4.6. Hitachi High-Tech Corporation
- 8.4.6.1. Company Overview
- 8.4.6.2. Financial Performance
- 8.4.6.3. Device Benchmarking
- 8.4.6.4. Strategic Initiatives
- 8.4.7. Shimadzu Corporation
- 8.4.7.1. Company Overview
- 8.4.7.2. Financial Performance
- 8.4.7.3. Device Benchmarking
- 8.4.7.4. Strategic Initiatives
- 8.4.8. DigiRad Corporation
- 8.4.8.1. Company Overview
- 8.4.8.2. Financial Performance
- 8.4.8.3. Device Benchmarking
- 8.4.8.4. Strategic Initiatives
- 8.4.9. UMG/DEL MEDICAL
- 8.4.9.1. Company Overview
- 8.4.9.2. Financial Performance
- 8.4.9.3. Device Benchmarking
- 8.4.9.4. Strategic Initiatives